OBSRV — Observe Medical ASA Cashflow Statement
0.000.00%
- NOK84.47m
- NOK125.30m
- NOK27.94m
- 16
- 34
- 51
- 23
Annual cashflow statement for Observe Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.9 | -36.9 | -26.3 | -50.7 | -60.3 |
Depreciation | |||||
Non-Cash Items | — | 8.68 | -6.34 | -7.09 | 7.41 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.34 | 3.38 | 7.07 | -4.45 | 14.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -14 | -21.6 | -22.1 | -51.3 | -24.5 |
Capital Expenditures | -2.14 | -1.24 | -4.89 | -4.93 | -8.02 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -6.84 | 0 | -53.4 | 0.392 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | -2.14 | -8.08 | -4.89 | -58.4 | -7.63 |
Financing Cash Flow Items | — | — | -0.001 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 16.2 | 48.2 | 16.1 | 121 | 31.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.136 | 18.5 | -16.1 | 10.8 | 0.036 |